AstraZeneca PLC (NASDAQ:AZN)
| 65.98 Delayed Data As of Jan 26 |  -0.64 / -0.96%Today’s Change | 52.65 Today|||52-Week Range 72.12 | -2.68% Year-to-Date |
Institutional investors control 17.27% of the outstanding shares in AZN. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2019, these large investors purchased a net $7.9 million shares.
| Mutual fund holders | 9.76% |
| Other institutional | 7.51% |
| Individual stakeholders | -- |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2022 | ASSENAGON ASSET MANAGEMENT SA (G... Bought 460.8 Thousand shares of AstraZeneca PLC |
| 1/05/2023 | IRISH LIFE INVESTMENT MANAGERS L... Bought 117.0 Thousand shares of AstraZeneca PLC |
| 12/31/2022 | LPL FINANCIAL LLC Bought 31.9 Thousand shares of AstraZeneca PLC |
Top 10 Owners of AstraZeneca PLC
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. (I... | 2.43% | 75,385,016 | 5,111,104,085 | -10,534,780 | -12.26% |
| Wellington Management Co. LLP | 1.69% | 52,246,916 | 3,542,340,905 | +3,948,994 | +8.18% |
| PRIMECAP Management Co. | 1.47% | 45,614,110 | 3,092,636,658 | -199,710 | -0.44% |
| Capital Research & Management Co.... | 1.30% | 40,325,623 | 2,734,077,239 | +942,624 | +2.39% |
| Fidelity Management & Research Co... | 0.68% | 21,178,034 | 1,435,870,705 | +2,256,078 | +11.92% |
| GQG Partners LLC | 0.59% | 18,377,731 | 1,246,010,162 | -337,929 | -1.81% |
| Franklin Advisers, Inc. | 0.47% | 14,499,844 | 983,089,423 | -354,884 | -2.39% |
| CIBC Private Wealth Advisors, Inc... | 0.35% | 10,813,940 | 733,185,132 | +83,177 | +0.78% |
| Norges Bank Investment Management | 0.30% | 9,308,677 | 631,128,301 | -70,000 | -0.75% |
| Fisher Asset Management LLC | 0.29% | 8,942,921 | 606,330,044 | -12,444,811 | -58.19% |
Top 10 Mutual Funds Holding AstraZeneca PLC
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Washington Mutual Investors Fund | 0.90% | 27,869,531 | 1,889,554,202 | +4,332,450 | +18.41% |
| Vanguard PRIMECAP Fund | 0.84% | 25,876,758 | 1,754,444,192 | -23,330 | -0.09% |
| Vanguard Wellington Fund | 0.51% | 15,874,492 | 1,076,290,558 | +967,711 | +6.49% |
| American Mutual Fund | 0.28% | 8,700,169 | 589,871,458 | +52,851 | +0.61% |
| Invesco QQQ Trust | 0.26% | 8,131,807 | 551,336,515 | -5,222 | -0.06% |
| T Rowe Price Health Sciences Fund | 0.26% | 7,999,227 | 542,347,591 | -21,468 | -0.27% |
| Vanguard Equity Income Fund | 0.21% | 6,618,375 | 448,725,825 | -84,025 | -1.25% |
| T Rowe Price Value Fund | 0.19% | 5,859,712 | 397,288,474 | -1,566,300 | -21.09% |
| Vanguard PRIMECAP Core Fund | 0.18% | 5,656,820 | 383,532,396 | 0 | 0.00% |
| Putnam Large Cap Value Fund | 0.15% | 4,607,933 | 312,417,857 | 0 | 0.00% |